Yahoo Web Search

Search results

1. Biodexa Pharmaceuticals Plc

   NasdaqCM: BDRX

   0.9685

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +0.0412 (+4.44%)

   At close:4:00 PM EDTMon. May 13, 2024

   0.9800 +0.01 (+1.19%)

   After hrs:5:35 PM EDTMon. May 13, 2024

   Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	0.9300
     High	0.9900
     Low	0.9203

   • Mkt Cap	4.25M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	0.9273
     52 Wk. Low	0.6700
     52 Wk. High	20.4000

   More about BDRX

   Related stocks

   • ZVSA
     ZyVersa Therapeutics, Inc.
     ZVSA
     5.46
     +1.68%
   • TCBP
     TC Biopharm (Holdings) Plc
     TCBP
     1.1300
     -0.88%
   • BGLC
     BioNexus Gene Lab Corp.
     BGLC
     0.5801
     -3.24%
   • ACON
     Aclarion, Inc.
     ACON
     0.2843
     +2.78%
   • FRGT
     Freight Technologies, Inc.
     FRGT
     0.6371
     -0.92%

   More on Yahoo Finance

2. seekingalpha.com › symbol › BDRXBiodexa Pharmaceuticals Plc (BDRX) Stock Price, Quote, News ...

   seekingalpha.com › symbol › BDRX

   • Cached

   5 days ago · A high-level overview of Biodexa Pharmaceuticals Plc (BDRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

   • Ratings

     Ratings - Biodexa Pharmaceuticals Plc (BDRX) Stock Price,...

   • Financials

     Financials - Biodexa Pharmaceuticals Plc (BDRX) Stock Price,...

   • Earnings

     Earnings - Biodexa Pharmaceuticals Plc (BDRX) Stock Price,...

     Transcripts

     · Earnings Estimates

     · Earnings Revisions

     · Earnings EPS Surprise

   • Dividends

     Dividends - Biodexa Pharmaceuticals Plc (BDRX) Stock Price,...

   • Growth

     Growth - Biodexa Pharmaceuticals Plc (BDRX) Stock Price,...

   • Momentum

     Momentum - Biodexa Pharmaceuticals Plc (BDRX) Stock Price,...

   • Peers

     Peers - Biodexa Pharmaceuticals Plc (BDRX) Stock Price,...

   • Options

     Get Options quotes for Biodexa Pharmaceuticals Plc (BDRX)....

3. www.marketbeat.com › stocks › NASDAQBiodexa Pharmaceuticals (BDRX) Stock Forecast & Price Target

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   3 days ago · The average twelve-month price prediction for Biodexa Pharmaceuticals is $8.00 with a high price target of $8.00 and a low price target of $8.00. Learn more on BDRX's analyst rating history. Do Wall Street analysts like Biodexa Pharmaceuticals more than its competitors?

4. marketwirenews.com › news-releases › biodexa-looksBDRX - Biodexa Looks To Prevent Or Delay The Worst Outcomes...

   marketwirenews.com › news-releases › biodexa-looks

   • Cached

   4 days ago · Registrational phase 3 clinical trials of Biodexa's (NASDAQ:BDRX) candidate eRapa are expected to start first quarter next year. The candidate was developed with private funds and acquired by Biodexa, its second portfolio expansion in less than six months, and is supported by a $17 million grant from the State of Texas.

5. People also ask

   Is biodexa Pharmaceuticals plc (BDRX) a risky stock?

   • It was a reverse split with a ratio of 1:80. BDRX has an Altman Z-Score of -24.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Biodexa Pharmaceuticals Plc (BDRX) stock, including valuation metrics, financial numbers, share information and more.

   Biodexa Pharmaceticals (BDRX) Statistics & Valuation Metrics - Stock An…

   stockanalysis.com/stocks/bdrx/statistics/

   See all results for this question

   Does BDRX pay a dividend?

   • The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom. More... BDRX does not currently pay a dividend. Pie chart with 8 slices. End of interactive chart.

   Biodexa Pharmaceuticals Plc (BDRX) Stock Price, Quote, News & Analysi…

   seekingalpha.com/symbol/BDRX

   See all results for this question

   Does biodexa Pharmaceuticals plc (BDRX) pay a dividend?

   • Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom. More... BDRX does not currently pay a dividend. Pie chart with 8 slices. End of interactive chart. Go Premium to see ratings on BDRX peers. A high-level overview of Biodexa Pharmaceuticals Plc (BDRX) stock.

   Biodexa Pharmaceuticals Plc (BDRX) Stock Price, Quote, News & Analysi…

   seekingalpha.com/symbol/BDRX

   See all results for this question

   How much is BDRX worth?

   • BDRX has a market cap or net worth of $1.87 million. The enterprise value is -$4.04 million. The next estimated earnings date is Tuesday, January 16, 2024, before market open. BDRX has 694,929 shares outstanding. The number of shares has increased by 363.27% in one year. The company has a current ratio of 3.18, with a Debt / Equity ratio of 0.10.

   Biodexa Pharmaceticals (BDRX) Statistics & Valuation Metrics - Stock An…

   stockanalysis.com/stocks/bdrx/statistics/

   See all results for this question

6. stockanalysis.com › stocks › bdrxBiodexa Pharmaceuticals Plc (BDRX ... - Stock Analysis

   stockanalysis.com › stocks › bdrx

   • Cached

   5 days ago · Detailed statistics for Biodexa Pharmaceuticals Plc (BDRX) stock, including valuation metrics, financial numbers, share information and more.

7. www.stocktitan.net › news › BDRXBiodexa Looks To Prevent Or Delay The Worst Outcomes For ...

   www.stocktitan.net › news › BDRX

   • Cached

   4 days ago · Registrational phase 3 clinical trials of Biodexa's (NASDAQ:BDRX) candidate eRapa are expected to start first quarter next year. The candidate was developed with private funds and acquired by Biodexa, its second portfolio expansion in less than six months, and is supported by a $17 million grant from the State of Texas.

8. www.stocktitan.net › news › BDRXBiodexa Pharmaceuticals plc American Depositary Shs ($BDRX ...

   www.stocktitan.net › news › BDRX

   • Cached

   4 days ago · Biodexa Pharmaceuticals (BDRX) is developing MTX110 for Diffuse Midline Glioma (DMG) and Recurrent Glioblastoma (rGBM), two aggressive brain cancers with poor prognoses. Early trials show promise in extending survival rates.

9. trendlyne.com › us › equityBiodexa Pharmaceuticals Plc - ADR RSI, Moving Averages ...

   trendlyne.com › us › equity

   • Cached

   5 days ago · Stock and sector reports. Recent broker upgrades ... BDRX 0.93 -0.07 (-7.00 %) 95.53% Fall from 52W High 162.9K ...